@article{6da01fcc11ca4250817a3a6715956919,
title = "Authors{\textquoteright} response",
author = "Spergel, {Jonathan M.} and Dellon, {Evan S.} and Liacouras, {Chris A.} and Ikuo Hirano and Javier Molina-Infante and Bredenoord, {Albert J.} and Furuta, {Glenn T.}",
note = "Funding Information: Disclosures: Dr Spergel is a consultant for Regeneron, DBV Technology, Kaleo, Grant-DBV Technology, Aimmune Therapeutics, Food Allergy Research Education and receives royalties from UpToDate. Dr Dellon is a consultant for Adare, Allakos, Alivio, Banner, Celgene/Receptos, Enumeral, GSK, Regeneron, and Shire; receives research funding from Adare, Celgene/Receptos, Miraca, Meritage, Nutricia, Regeneron, and Shire; receives educational grants from Banner and Holoclara. Dr Liacouras is a consultant for Shire, Adare, Abbott Nutrition, Receptos, and TEVA. Dr Hirano is a consultant for Adare and Allakos. Dr Molina-Infante receives research funding from and is a consultant for Dr Falk Pharma. Dr Bredenoord has nothing to disclose. Dr Furuta is the founder of EnteroTrack, is a consultant for Shire, and receives royalties from UpToDate. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2018",
month = dec,
doi = "10.1016/j.anai.2018.10.015",
language = "English (US)",
volume = "121",
pages = "747--748",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "6",
}